CLINICAL_TRIALS
trial_result
· 2026-03-02
Clinical Trial Update: Entinostat Neuroendocrine (NE) Tumor [Phase 2]
Summary
Phase 2 trial of entinostat in neuroendocrine tumors was terminated. Results were posted on 2026-03-02.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Antonio Fojo | Conditions: Neuroendocrine Tumors | Phase 2 | Status: TERMINATED | Results posted: 2026-03-02